REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $68,334,204 | -65.4% | 670,206 | -69.1% | 1.98% | -66.0% |
Q1 2023 | $197,230,574 | +7748.4% | 2,169,276 | +2069.3% | 5.82% | +7876.7% |
Q3 2022 | $2,513,000 | +72.5% | 100,000 | +124.8% | 0.07% | +151.7% |
Q1 2022 | $1,457,000 | +84.2% | 44,475 | +359.6% | 0.03% | +38.1% |
Q3 2018 | $791,000 | – | 9,677 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 3,023,349 | $285,253,000 | 33.71% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 245,000 | $23,116,000 | 17.80% |
Prosight Management, LP | 124,965 | $11,790,000 | 5.94% |
Cormorant Asset Management, LP | 806,150 | $76,060,000 | 4.37% |
LBJ Family Wealth Advisors, Ltd. | 44,096 | $3,710,000 | 2.74% |
MORGENS WATERFALL VINTIADIS & CO INC | 34,350 | $3,241,000 | 2.23% |
Biondo Investment Advisors, LLC | 73,090 | $6,896,000 | 1.64% |
P.A.W. CAPITAL CORP | 15,000 | $1,415,000 | 1.53% |
EMERALD ADVISERS, LLC | 387,369 | $36,548,000 | 1.47% |
SPHERA FUNDS MANAGEMENT LTD. | 112,769 | $10,640,000 | 1.46% |